Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-15

Clinical Trial Update: Effect of Topic Pirfenidone in Diabetic Ulcers [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating topical pirfenidone for diabetic foot ulcers has completed. The update notes the study status as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pirfenidone (topical) (pirfenidone)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Diabetic Foot Ulcers | Phase 3 | Status: COMPLETED